Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2023		188,951,643
Beginning balance at Dec. 31, 2023	$ 158,071	$ 189	$ 1,037,015	$ (880,258)	$ 1,125
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(46,575)			(46,521)	(54)
Issuance of common stock upon vesting of restricted stock units (in shares)		2,277,545
Issuance of common stock upon vesting of restricted stock units	2	$ 2
Forfeitures (in shares)		(2,799)
Shares withheld related to net restricted stock settlement (in shares)		(69,820)
Shares withheld related to net restricted stock settlement	(350)		(350)
Equity-based compensation	20,854		20,854
Noncontrolling interest attributable to subsidiary	15				15
Ending Balance (in shares) at Mar. 31, 2024		191,156,569
Ending balance at Mar. 31, 2024	$ 132,017	$ 191	1,057,519	(926,779)	1,086
Beginning balance (in shares) at Dec. 31, 2024	191,778,639	191,778,639
Beginning balance at Dec. 31, 2024	$ 100,955	$ 192	1,107,952	(1,008,293)	1,104
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(9,354)			(9,114)	(240)
Issuance of common stock upon vesting of restricted stock units (in shares)		5,864,819
Forfeitures (in shares)		(277)
Equity-based compensation	$ 17,187	$ 6	17,181
Stock options exercised (in shares)	24,472	24,472
Stock options exercised	$ 207		207
Ending Balance (in shares) at Mar. 31, 2025	197,667,653	197,667,653
Ending balance at Mar. 31, 2025	$ 108,995	$ 198	$ 1,125,340	$ (1,017,407)	$ 864